Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 346 AL 360

Integrative analysis of summary data from GWAS and eQTL studies implicates genes differentially expressed in Alzheimer's disease

Lee B, Yao X, Shen L; Alzheimer’s Disease Neuroimaging Initiative.

BMC Genomics. 2022 Jun 2;23(Suppl 4):414. doi: 10.1186/s12864-022-08584-8.

Defective mitophagy and the etiopathogenesis of Alzheimer's disease

Zeng K, Yu X, Mahaman YAR, Wang JZ, Liu R, Li Y, Wang X.

Transl Neurodegener. 2022 Jun 3;11(1):32. doi: 10.1186/s40035-022-00305-1.

Recent Update on the Alzheimer's Disease Progression, Diagnosis and Treatment Approaches

Malaiya A, Singhai M, Singh M, Prajapati SK, Choudhury H, Fatima M, Alexander A, Dubey SK, Greish K, Kesharwani P.

Curr Drug Targets. 2022;23(10):978-1001. doi: 10.2174/1389450123666220526155144.

TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target

Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, Wang M, Yu CJ, Tang Y.

Mol Neurodegener. 2022 Jun 3;17(1):40. doi: 10.1186/s13024-022-00542-y.

An HIT-Supported Care Coordination Framework for Reducing Structural Racism and Discrimination for Patients With ADRD

Chen J, Buchongo P, Spencer MRT, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2022 Nov;30(11):1171-1179. doi: 10.1016/j.jagp.2022.04.010. Epub 2022 May 6.

The future of stem cell therapies of Alzheimer's disease

Wang ZB, Wang ZT, Sun Y, Tan L, Yu JT.

Ageing Res Rev. 2022 Sep;80:101655. doi: 10.1016/j.arr.2022.101655. Epub 2022 Jun 2.

Signal pathways in the treatment of Alzheimer's disease with traditional Chinese medicine

Ding MR, Qu YJ, Hu B, An HM.

Biomed Pharmacother. 2022 Aug;152:113208. doi: 10.1016/j.biopha.2022.113208. Epub 2022 May 31.

The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer's Disease

Qin Q, Wang M, Yin Y, Tang Y.

Front Immunol. 2022 May 19;13:845897. doi: 10.3389/fimmu.2022.845897. eCollection 2022.

Necroptosis in Alzheimer's disease: Potential therapeutic target

Richard R, Mousa S.

Biomed Pharmacother. 2022 Aug;152:113203. doi: 10.1016/j.biopha.2022.113203. Epub 2022 Jun 2.

New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease

Wu JJ, Yang Y, Wan Y, Xia J, Xu JF, Zhang L, Liu D, Chen L, Tang F, Ao H, Peng C.

Biomed Pharmacother. 2022 Aug;152:113207. doi: 10.1016/j.biopha.2022.113207. Epub 2022 Jun 3.

Resources for Enhancing Alzheimer's Caregiver Health in Vietnam (REACH VN): Exploratory Analyses of Outcomes of a Cluster Randomized Controlled Trial to Test the Feasibility and Preliminary Efficacy of a Family Dementia Caregiver Intervention in Vietnam

Tran D, Nguyen H, Pham T, Nguyen AT, Nguyen HT, Nguyen NB, Harvey D, Hinton L.

Am J Geriatr Psychiatry. 2022 Aug;30(8):878-882. doi: 10.1016/j.jagp.2022.04.011. Epub 2022 May 6.

Neuroimmune contributions to Alzheimer's disease: a focus on human data

Haage V, De Jager PL.

Mol Psychiatry. 2022 Aug;27(8):3164-3181. doi: 10.1038/s41380-022-01637-0. Epub 2022 Jun 6.

Neuroprotective Potential of Curcuminoids in Modulating Alzheimer's Disease via Multiple Signaling Pathways

Shabbir A, Rehman K, Akbar M, Akash MSH.

Curr Med Chem. 2022;29(34):5560-5581. doi: 10.2174/0929867329666220607161328.

The Locus Coeruleus - Noradrenaline system: Looking into Alzheimer's therapeutics with rose coloured glasses

Behl T, Kaur I, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Bhatia S, Bungau S.

Biomed Pharmacother. 2022 Jul;151:113179. doi: 10.1016/j.biopha.2022.113179. Epub 2022 May 27.

The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer's disease

Zhao X, Xiong L, She L, Li L, Huang P, Liang G.

Biomed Pharmacother. 2022 Jul;151:113188. doi: 10.1016/j.biopha.2022.113188. Epub 2022 May 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias